logo
Jehoshaphat Research short Main Street Capital, sees likely dividend cut

Jehoshaphat Research short Main Street Capital, sees likely dividend cut

Yahoo15-05-2025
In a recently published report, Jehoshaphat Research said it is short Main Street (MAIN) Capital, 'a BDC which in our opinion has been systematically inflating the fair values of its investment portfolio. These illiquid valuations imply enormous unrealized gains, while its track record of actual investment realizations over time is negative (cumulative realized losses). The unrealized gains are concentrated where there are no third-party marks available to sanity-check these absurd valuations. Going investment-by-investment illustrates the absurdity at a deeper level, as does cutting the portfolio in a variety of ways and analyzing those slices against comparable 'slices' of peers'.' 'In our analysis, these unrealized gains have inflated MAIN's NAV by ~40% and its EPS and ROE similarly. However, they do nothing to support the dividend – a dividend which is no longer covered by underlying portfolio cash flows and which we think will be cut, just as it was cut the last time internal cash flows fell like this.'
Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on MAIN:
Disclaimer & DisclosureReport an Issue
Main Street price target lowered to $53 from $58 at Oppenheimer
Main Street price target lowered to $54 from $62 at Truist
Main Street Capital Reports Strong Q1 2025 Results
Main Street Capital Reports Strong Earnings Amid Market Challenges
Main Street reports Q1 distributable NII $1.01, consensus $1.02
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Kepler Capital Reaffirms Their Buy Rating on Neste Corporation (0O46)
Kepler Capital Reaffirms Their Buy Rating on Neste Corporation (0O46)

Business Insider

timean hour ago

  • Business Insider

Kepler Capital Reaffirms Their Buy Rating on Neste Corporation (0O46)

Kepler Capital analyst Pablo Cuadrado maintained a Buy rating on Neste Corporation on July 24 and set a price target of €13.80. The company's shares closed last Friday at €14.61. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Cuadrado is a 4-star analyst with an average return of 7.6% and a 56.55% success rate. Cuadrado covers the Industrials sector, focusing on stocks such as Bureau Veritas, Construcciones y Auxiliar de Ferrocarriles, and SGS SA. In addition to Kepler Capital , Neste Corporation also received a Buy from Goldman Sachs's Michele Della Vigna in a report issued on July 25. However, on the same day, Banco Santander downgraded Neste Corporation (LSE: 0O46) to a Hold.

Boss Energy (BQSSF) Gets a Hold from Macquarie
Boss Energy (BQSSF) Gets a Hold from Macquarie

Business Insider

timean hour ago

  • Business Insider

Boss Energy (BQSSF) Gets a Hold from Macquarie

Macquarie analyst maintained a Hold rating on Boss Energy today and set a price target of A$4.45. The company's shares closed last Friday at $2.39. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. In addition to Macquarie, Boss Energy also received a Hold from RBC Capital's Alistair Rankin in a report issued on July 17. However, today, Morgan Stanley downgraded Boss Energy (Other OTC: BQSSF) to a Sell. The company has a one-year high of $3.11 and a one-year low of $1.26. Currently, Boss Energy has an average volume of 23.73K.

Barclays Sticks to Its Buy Rating for Galderma Group AG (GALD)
Barclays Sticks to Its Buy Rating for Galderma Group AG (GALD)

Business Insider

time3 hours ago

  • Business Insider

Barclays Sticks to Its Buy Rating for Galderma Group AG (GALD)

Barclays analyst Yihan Li maintained a Buy rating on Galderma Group AG on July 25 and set a price target of CHF140.00. The company's shares closed last Friday at CHF134.50. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Li is ranked #6568 out of 9862 analysts. Galderma Group AG has an analyst consensus of Strong Buy, with a price target consensus of CHF130.52, which is a -2.96% downside from current levels. In a report released on July 25, Citi also maintained a Buy rating on the stock with a CHF140.00 price target. Based on Galderma Group AG's latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of CHF1.93 billion and a net profit of CHF160.43 million. In comparison, last year the company earned a revenue of CHF1.84 billion and had a GAAP net loss of CHF54.18 million

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store